Career Advisor

Clinical Trials Career Guide and Counseling

We can help you connect with ministry contacts who can provide more information about clinical trials career streams, and who are knowledgeable about current and future hiring needs and clinical trials career development in these areas. Contact us to find out more about clinical trials career path, clinical trials career planning, clinical trials career assessment and clinical trials career choices. what clinical trials career opportunities may be just around the corner and how you can build a satisfying future.

Question: what percentage of clinical trials ultimately result in an effective drug? I know it takes a while to go through with a clinical trial (10-15 years?) but how many of those clinical trials fail and how many result in production of a drug? Thank you!

Answer: About seven to fifteen years. The shortest time I've ever heard of a drug going from lab to actual use was the original HIV protease inhibitor, at the time there was essentially no treatment for HIV/AIDS, and a diagnosis usually meant death in under a year. The FDA basically pulled out all the stops for it. There's three phases of clinical trials, and precliical before that. The overwhelming majority of drugs die in preclinical trials. About 7-9% of what gets into Phase I trials gets to move forward. It's hard to go with an exact number, because high throughput drug screening - which is where they test a very large number of compounds looking for a specific behavior skews it. Of he compounds that are looked at seriously though, easily under 1% make it to the point where they can be sold.


Clinical Trials Career Information and Opportunities

AIDS researchers sideline women

Los Angeles Times
Although they account for 25% of those living with HIV in the US, women are significantly underrepresented in clinical trials. Claudia Pena, shown in 2005, told her children that she was HIV positive a year earlier. Women account for 25% of those ...
 

Bavarian Nordic to Report New PROSTVACR Clinical Data at the American Society ...

Reuters
"Interim analysis of a phase 2 randomized clinical trial of Samarium-153 (Sm-153) with or without PSA-TRICOM vaccine in metastatic castration resistant prostate cancer (mCRPC) after docetaxel", abstract number 2526, Poster Discussion Session, ...
 

Updated News

Phase I Clinical Trial Shows Drug Shrinks Melanoma Brain Metastases
Science Daily (press release)
 

U.S. News & World Report

ZYTIGAź (abiraterone acetate) Data to be Presented at 2012 American Society of ...
MarketWatch (press release)
 

ArQule and Daiichi Sankyo Announce Completion of Patient Recruitment in Phase ...

MarketWatch (press release)
(4) "We would like to thank the patients, investigators and clinical sites who are participating in the MARQUEE trial," said Brian Schwartz, chief medical officer of ArQule. "Their commitment, diligence and care have been essential in the timely ...
 

The Guardian

A Meeting of the Medical Minds
Washington Post
 

Experts call for clinical trials to test non-skeletal benefits of vitamin D

Medical Xpress
The Endocrine Society's new scientific statement published online today represents the first comprehensive evaluation of both the basic and clinical evidence related to the non-skeletal effects of vitamin D. The statement addresses current research ...
 

Genetic Immunity Clinical Trial Data Published in PLoS ONE

MarketWatch (press release)
MCLEAN, Va and BUDAPEST, Hungary, May 17, 2012 (GlobeNewswire via COMTEX) -- Genetic Immunity Inc., a privately-held, biopharmaceutical company developing Langerhans cell-targeted immunotherapies, published its human proof-of-concept clinical trial, ...
 

Esperance Pharmaceuticals Initiates Phase 2 Clinical Trial of its Novel ...

MarketWatch (press release)
The Phase 2 study design is based on the recent successful completion of a Phase 1 study of EP-100 in advanced solid tumors, the results of which will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in June this year.
 

Human drug trials: Expert lauds Karnataka

Daily News & Analysis
By DNA Correspondent | Place: Bangalore | Agency: DNA Even though India makes a modest 2% contribution towards human drug trials in the world, 12% of this happens in Karnataka. At a workshop organised by the Indian Society for Clinical Research (ISCR), ...